Abnormalities in Skeletal Muscle Mitochondrial Function Linked to Exercise Intolerance in HFpEF Patients: JAMA Dr. Mahalakshmi Sivashankaran17 May 2023 8:00 PM ISTUSA: A ground-breaking study published JAMA: Cardiology has shed light on the pathophysiology of exercise intolerance in patients with heart failure...
AAC's expert consensus on management of heart failure with preserved ejection fraction: Key takeaways Medha Baranwal25 April 2023 10:15 AM ISTUSA: The American College of Cardiology (ACC) has released a 2023 expert consensus decision pathway on managing heart failure with preserved ejection...
Simple score useful to identify transthyretin amyloid cardiomyopathy in HFpEF patients Medha Baranwal13 April 2023 10:15 AM ISTUSA: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of heart failure with preserved ejection fraction (HFpEF). ATTR-CM can be diagnosed with...
Personalized accelerated pacing safe and improves QoL in HFpEF patients with pacemaker Medha Baranwal9 Feb 2023 11:45 AM ISTUSA: Treatment with a moderately accelerated, personalized pacing rate was found to be safe and improved quality of life among HFpEF (heart failure...
Chronic Lack of exercise linked to diminished cardiorespiratory fitness in patients with HFpEF: JACC Medha Baranwal26 Oct 2022 10:45 AM ISTGermany: Exercise deficiency, defined as chronic lack of exercise, is linked with reduced cardiac output and chamber size, cardiac atrophy, and...
Riociguat significantly improves haemodynamics in patients with pulmonary hypertension with HFpEF: DYNAMIC Trial Dr. Kamal Kant Kohli17 Oct 2022 11:15 AM ISTEUROPE: According to a study published in the European Heart Journal, the vasodilator riociguat enhanced haemodynamics in patients with pulmonary...
Boehringer Ingelheim's empagliflozin gets CDSCO nod for heart failure with preserved ejection fraction Medical Dialogues Bureau19 May 2022 4:19 PM ISTNew Delhi: Boehringer Ingelheim, one of the world's leading, research-driven pharmaceutical companies, has received approval from the Central Drugs...
CAD and CMD common in HFpEF patients and may serve as therapeutic targets: JAMA Medha Baranwal15 Oct 2021 10:30 AM ISTUK: A recent study in the journal JAMA Cardiology has shed light on the prevalence of coronary artery disease (CAD) and coronary microvascular...
Troponins may be useful guide for ARNI therapy in HFpEF, finds JACC study dr. Abhimanyu Uppal24 July 2021 10:21 AM ISTHeart failure (HF) with preserved ejection fraction (HFpEF) accounts for one-half of HF cases, and research has been ongoing for many years to find...
Splanchnic nerve ablation effective in HF with preserved ejection fraction, shows first-in-human study. dr. Abhimanyu Uppal7 May 2021 10:45 AM ISTRecent research has indicated that the underlying pathophysiology for clinical manifestations of heart failure with preserved ejection fraction...
Optimal control of blood sugar, BP, and AF reduces risk of heart failure: Study Medha Baranwal8 Sept 2020 11:30 AM ISTChina: Conservative blood sugar control, and rhythm control of atrial fibrillation (AF), in addition to intensive BP control, are crucial for delaying...
